Poxel S.A. (EPA:POXEL)
France · Delayed Price · Currency is EUR 0.3340
-0.0660 (-16.50%)
At close: Jan 30, 2026
Poxel Market Cap
Poxel has a market cap or net worth of €17.95 million as of January 30, 2026. Its market cap has increased by 7.86% in one year.
Market Cap
17.95M
Enterprise Value
77.90M
Revenue
7.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.33
Market Cap Chart
Since February 6, 2015, Poxel's market cap has decreased from 193.09M to 17.95M, a decrease of -90.71%. That is a compound annual growth rate of -19.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 17.95M | 42.74% |
| Dec 31, 2025 | 12.57M | 69.26% |
| Dec 31, 2024 | 7.43M | -61.80% |
| Dec 29, 2023 | 19.45M | -28.41% |
| Dec 30, 2022 | 27.16M | -80.72% |
| Dec 31, 2021 | 140.90M | -22.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fermentalg | 41.62M |
| THX Pharma Société Anonyme | 35.73M |
| Nicox | 32.87M |
| Advicenne | 23.94M |
| Aelis Farma | 23.65M |
| genOway Société anonyme | 23.33M |
| GenSight Biologics | 18.26M |
| NFL Biosciences | 16.25M |